EUDA PE Ratio & Valuation, Is EUDA Overvalued

Historical Valuation

EUDA Health Holdings Ltd (EUDA) is now in the Fair zone, suggesting that its current forward PS ratio of 5.15 is considered Fairly compared with the five-year average of -11.35. The fair price of EUDA Health Holdings Ltd (EUDA) is between 0.13 to 0.77 according to relative valuation method.

Relative Value

Fair Zone

0.13-0.77

Current Price：0.37

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is EUDA Health Holdings Ltd (EUDA) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

EUDA Health Holdings Ltd (EUDA) has a current Price-to-Book (P/B) ratio of -24.64. Compared to its 3-year average P/B ratio of -17.32, the current P/B ratio is approximately 42.30% higher. Relative to its 5-year average P/B ratio of -12.70, the current P/B ratio is about 94.04% higher. EUDA Health Holdings Ltd (EUDA) has a Forward Free Cash Flow (FCF) yield of approximately -2.31%. Compared to its 3-year average FCF yield of -2.75%, the current FCF yield is approximately -15.90% lower. Relative to its 5-year average FCF yield of -3.67%, the current FCF yield is about -37.17% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for EUDA competitors is 2.29, providing a benchmark for relative valuation. EUDA Health Holdings Ltd Corp (EUDA.O) exhibits a P/S ratio of 5.15, which is 125% above the industry average. Given its robust revenue growth of -95.71%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of EUDA increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of EUDA in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is EUDA currently overvalued or undervalued?

What is EUDA Health Holdings Ltd (EUDA) fair value?

EUDA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of EUDA Health Holdings Ltd (EUDA) is between 0.13 to 0.77 according to relative valuation method.

How does EUDA's valuation metrics compare to the industry average?

The average P/S ratio for EUDA's competitors is 2.29, providing a benchmark for relative valuation. EUDA Health Holdings Ltd Corp (EUDA) exhibits a P/S ratio of 5.15, which is 125.00% above the industry average. Given its robust revenue growth of -95.71%, this premium appears unsustainable.

What is the current P/B ratio for EUDA Health Holdings Ltd (EUDA) as of Mar 22 2026?

As of Mar 22 2026, EUDA Health Holdings Ltd (EUDA) has a P/B ratio of -24.64. This indicates that the market values EUDA at -24.64 times its book value.

What is the current FCF Yield for EUDA Health Holdings Ltd (EUDA) as of Mar 22 2026?

As of Mar 22 2026, EUDA Health Holdings Ltd (EUDA) has a FCF Yield of -2.31%. This means that for every dollar of EUDA Health Holdings Ltd's market capitalization, the company generates -2.31 cents in free cash flow.

What is the current Forward P/E ratio for EUDA Health Holdings Ltd (EUDA) as of Mar 22 2026?

As of Mar 22 2026, EUDA Health Holdings Ltd (EUDA) has a Forward P/E ratio of 42.78. This means the market is willing to pay $42.78 for every dollar of EUDA Health Holdings Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for EUDA Health Holdings Ltd (EUDA) as of Mar 22 2026?

As of Mar 22 2026, EUDA Health Holdings Ltd (EUDA) has a Forward P/S ratio of 5.15. This means the market is valuing EUDA at $5.15 for every dollar of expected revenue over the next 12 months.

EUDA Valuation